SEATTLE--(BUSINESS WIRE)--Adaptive Biotechnologies, the leader in next generation sequencing (NGS) and expert bioinformatics to profile T- and B-cell receptors of the adaptive immune system, announced today that Chad Robins, President, Chief Executive Officer and Co-founder, will present during the 34th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2016 at 4:00 p.m. PST in San Francisco, CA.
